Asia Spotlight: Improve Quality Or You're Out, Says China FDA Commissioner

10 Aug 2015
News

Executive Summary

In a rare public speech, China FDA Commissioner Bi Jingquan calls for improved drug quality and an ecosystem to reward high-quality medicines, highlighting the agency’s drive to step up enforcement amid another recent scandal that has revealed broad quality problems.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Industries
BioPharmaceutical
Regions
Asia Pacific

China

Subjects
Regulation
Quality

Related Companies

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

BioPharmaceutical China Regulation

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS057054

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS057054

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Asia Spotlight: Improve Quality Or You're Out, Says China FDA Commissioner

News

Executive Summary

Related Content

China Regulatory Shakeup: Top Regulator Out, Commissioner Reprimanded Amid Vaccine Scandal

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert